FindTrial
Sign In

FIbroscan To detect LIVER fibrosis in patients with inflammatory bowel disease receiving long-term thiopurine therapy

FIbroscan To detect LIVER fibrosis in patients with inflammatory bowel disease receiving long-term thiopurine therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21349
Enrollment
Unknown
Registered
2016-06-02
Start date
2016-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease, thiopurines, hepatotoxicity, hepatotoxiciteit, liver fibrosis, lever fibrose

Interventions

Fibroscan: Also called transient elastography, used to assess liver stiffness (measured in kPa) without invasive investigation.

Sponsors

VU University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients (>18 y/o) Diagnosed with inflammatory bowel disease (i.e. Crohn’s disease, ulcerative colitis or IBD unclassified)

Exclusion criteria

Exclusion criteria: Concomitant known liver pathology (e.g. viral hepatitis, liver cancer, liver cirrhosis, liver fibrosis)

Design outcomes

Primary

MeasureTime frame
Liver stiffness score (Metavir), F0-F4—

Contacts

Public ContactB. Meijer

VU University Medical Center

b.meijer1@vumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)